Can blood flow assays help to identify clinical relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3?
Scientific and Standardization Committee Communications: On behalf of the Biorheology Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis
J. J. Zwaginga1, K. S. Sakariassen2, M. R. King3, T. G. Diacovo4, E. F. Grabowski5, G. Nash6,
M. Hoylaerts7, J. W. M. Heemskerk8 and Biorheology Subcommittee of the SSC of the ISTH
Summary: (Journal of Thrombosis and Haemostasis 5 (12) , 2547–2549 doi:10.1111/j.1538-7836.2007.02807.x)
Correspondence to:
1J.J. Zwaginga
Department of Experimental Immunohematology Sanquin Research
Amsterdam and Immunohematology Bloodtransfusion.
University Hospital Leiden
PO Box 9600
2300 RC Leiden , The Netherlands
Tel: 31 71 5263800/4006
FAX: 31 71 5216751
Email: j.j.zwaginga@lumc.nl
2KellSa s.a.s., Biella, Italy
3Dept. of Biomedical Engineering, University of Rochester, Rochester, NY, USA
4Depts. of Pediatrics and Pathology, Columbia University Medical Center, New York, NY, USA
5Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital-Harvard Medical School, Boston, MA, USA
6Centre for Cardiovascular Sciences and MRC Centre for Immune Regulation, University of Birmingham, Birmingham, UK
7Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium
8Dept. of Biochemistry, CARIM, University of Maastricht, Maastricht, NL